Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences
Oslo, Norway 26 June 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing next generation circular RNA vector technology for gene therapy, today announces that CEO Dr. Erik Digman Wiklund and CSO Dr. Victor Levitsky have been invited to speak at two upcoming biopharma industry RNA conferences in Frankfurt, Germany, and San Diego, USA.The European mRNA conference 2024 Title: Is circular RNA surpassing mRNA as the RNA format for the future? Time & place: 26 June 2024, 11:00 CEST, Frankfurt, Germany Presenter: